The New Era of Biosimilar Therapeutics for Multiple Sclerosis - AcademicCME

Mar 22, 2024

- Mar 21, 2025

The New Era of Biosimilar Therapeutics for Multiple Sclerosis

0.75

Claim your AMA PRA Category 1 Credit(s)

Login to take this course.

This course is available for logged in users only. Please login or register to take the course.

Related Courses

Cardiometabolic

LIVE UPDATE FROM ACC25: More Support for the “Factor XI Hypothesis”

Cardiometabolic

MANAGEMENT OF PSVT: UPDATE FROM ACC25

Best Practices in Contract Negotiation: Knowing Your Worth as an MS Specialist